The association between liver fibrosis and depression in patients after ischemic stroke

BMC Neurol. 2023 Jan 31;23(1):50. doi: 10.1186/s12883-023-03091-z.

Abstract

Background and objective: Liver fibrosis has been considered a predictor of cardiovascular disease. This study aimed to evaluate whether the degree of liver fibrosis is related to post-stroke depression (PSD) at 3 months follow-up.

Methods: We prospectively and continuously enrolled patients with first-ever ischemic stroke from June 2020 to January 2022. Liver fibrosis was measured after admission by calculating the Fibrosis-4 index (FIB-4) and stratified into two categories (< 2.67 versus ≥ 2.67). Patients with a 17-item Hamilton Depression Scale score > 7 were further evaluated using the Chinese version of the structured clinical interview of DSM-IV, for diagnosing PSD at 3 months.

Results: A total of 326 patients (mean age 66.6 years, 51.5% male) were recruited for the study. As determined by the FIB-4 score, 80 (24.5%) patients had advanced liver fibrosis. During the follow-up, PSD was observed in 91 patients, which accounted for 27.9% (95% confidence interval [CI] 25.5%-30.5%) of the cohort. The prevalence of advanced liver fibrosis was higher in PSD patients than those without PSD (40.0% versus 24.0%; P = 0.006). After adjustment for covariates in the multivariate logistic analysis, advanced fibrosis was significantly associated with PSD (odds ratio [OR], 1.88; 95% CI, 1.03-3.42; P = 0.040). Similar results were found when the FIB-4 was analyzed as a continuous variable.

Conclusions: This study found that advanced liver fibrosis was associated with an increased risk of 3-month PSD. FIB-4 score may be valuable for screening depressive symptoms in ischemic stroke patients.

Keywords: Depressive symptoms; Fibrosis-4 index; Ischemic stroke; Liver fibrosis; Risk factor.

MeSH terms

  • Aged
  • Depression* / epidemiology
  • Depression* / etiology
  • Female
  • Humans
  • Ischemic Stroke* / complications
  • Ischemic Stroke* / epidemiology
  • Liver Cirrhosis* / complications
  • Liver Cirrhosis* / epidemiology
  • Male